Last updated on September 2015

Corticosteroid Therapy for Severe Community-Acquired Pneumonia


Brief description of study

The purpose of the present study is to assess the efficacy of methylprednisolone as an adjuvant therapy in patients with severe community-acquired pneumonia (CAP) (PSI 4-5). The hypothesis of the study is that methylprednisolone can decrease the mortality of severe CAP without any significant side effects,with reduction of the time to clinical stability and failure rate of treatment.

Clinical Study Identifier: NCT02552342

Find a site near you

Start Over